With news that two United Kingdom health workers had allergic reactions to the Pfizer-BioNTech Covid-19 vaccine, White House vaccine chief Moncef Slaoui said Wednesday that the US Food and Drug Administration will likely consider this information as it makes its determination on emergency use authorization.
National Health Service England Wednesday said that people with a “significant history of allergic reaction” to vaccine, medicine or food or those who have been advised to carry an adrenaline autoinjector should not be given this vaccine in the UK.
Slaoui, the head of Operation Warp Speed, said at a news briefing that people with a history of severe allergic reaction had been excluded from the clinical trials, so he said, the adverse reactions from the two health professionals was “new news.”
The FDA will ultimately determine if people with severe allergic reactions should be allowed to get the vaccine or not.
“The expectation will be that subjects with known severe allergic reactions should not take the vaccine, until we understand exactly what happened here,” Slaoui said.
CNN's Phil Black reports. Watch below: